01.07.2001 | Case Report
Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody
Erschienen in: International Journal of Hematology | Ausgabe 1/2001
Einloggen, um Zugang zu erhalten